The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, raised a $175 million Series B round on Jan. 12. Founded in 2020, Tune focuses on epigenome editing ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

ISELIN, N.J., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...

Ramona, a Durham provider of advanced imaging technology for life sciences, has launched a live-cell imaging system that ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

After hours: February 3 at 6:54:22 PM EST Loading Chart for BTAI ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

But, that excitement subsided once they got on their group dates. Discussions continue for new Durham Convention Center From 2019 to 2024 the Durham Convention Center lost out on $27 million in ...